Eli Lilly invests $3 billion to expand Wisconsin factory for diabetes and obesity drugs

abcnews.go.com

Eli Lilly is investing $3 billion to expand its factory in Kenosha County, Wisconsin. This expansion aims to increase production of its diabetes and obesity drugs, Mounjaro and Zepbound, which generated $4.4 billion in sales last quarter. Construction on the Wisconsin facility is set to begin next year. This investment is part of a broader strategy, as Lilly has announced over $23 billion in manufacturing expansions globally since 2020. The company purchased the Kenosha factory earlier this year to help meet rising demand for its injectable products. Lilly has also revealed other significant manufacturing projects near its headquarters in Indianapolis.


With a significance score of 3.5, this news ranks in the top 6.2% of today's 28423 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: